JP2025511167A5 - - Google Patents

Info

Publication number
JP2025511167A5
JP2025511167A5 JP2024557991A JP2024557991A JP2025511167A5 JP 2025511167 A5 JP2025511167 A5 JP 2025511167A5 JP 2024557991 A JP2024557991 A JP 2024557991A JP 2024557991 A JP2024557991 A JP 2024557991A JP 2025511167 A5 JP2025511167 A5 JP 2025511167A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
myostatin
sequence
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/058218 external-priority patent/WO2023187022A1/en
Publication of JP2025511167A publication Critical patent/JP2025511167A/ja
Publication of JP2025511167A5 publication Critical patent/JP2025511167A5/ja
Pending legal-status Critical Current

Links

JP2024557991A 2022-04-01 2023-03-30 顔面肩甲上腕型筋ジストロフィー(fshd)の新規な処置 Pending JP2025511167A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22166261 2022-04-01
EP22166261.2 2022-04-01
PCT/EP2023/058218 WO2023187022A1 (en) 2022-04-01 2023-03-30 New treatment for facioscapulohumeral muscular dystrophy (fshd)

Publications (2)

Publication Number Publication Date
JP2025511167A JP2025511167A (ja) 2025-04-15
JP2025511167A5 true JP2025511167A5 (https=) 2026-04-07

Family

ID=81328333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557991A Pending JP2025511167A (ja) 2022-04-01 2023-03-30 顔面肩甲上腕型筋ジストロフィー(fshd)の新規な処置

Country Status (11)

Country Link
US (1) US20250171526A1 (https=)
EP (1) EP4504779A1 (https=)
JP (1) JP2025511167A (https=)
KR (1) KR20240165959A (https=)
CN (1) CN119053619A (https=)
AU (1) AU2023246859A1 (https=)
CA (1) CA3255735A1 (https=)
IL (1) IL315473A (https=)
MX (1) MX2024011922A (https=)
TW (1) TW202346345A (https=)
WO (1) WO2023187022A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
KR101860280B1 (ko) 2014-12-19 2018-05-21 추가이 세이야쿠 가부시키가이샤 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법
AR107078A1 (es) 2015-12-18 2018-03-21 Chugai Pharmaceutical Co Ltd Anticuerpo antimiostatina, polipéptidos que contienen regiones fc variantes así como métodos de uso

Similar Documents

Publication Publication Date Title
JP2024016177A5 (https=)
JP2020518599A5 (https=)
JP2023109942A5 (https=)
JP2023517236A5 (https=)
FI4045533T3 (fi) Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2)
JP2019534003A5 (https=)
JP2022523972A5 (https=)
JP2011528902A5 (https=)
JP2006522830A5 (https=)
JP2025032102A5 (https=)
JP2012504955A5 (https=)
JP2021501579A5 (https=)
JP2024537864A5 (https=)
JP2024518536A5 (https=)
JP2024540226A5 (https=)
JP2020533382A5 (https=)
JP2023510199A5 (https=)
JP2025509266A5 (https=)
JP2021523138A5 (https=)
JP2024540395A5 (https=)
JP2022535523A5 (https=)
JP2021532176A5 (https=)
JP2023511956A5 (https=)
JP2023103352A5 (https=)
JP2022514561A5 (https=)